Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Peripheral Nervous System Agents: later-stage trial registry

3 of 4 indexed Peripheral Nervous System Agents trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Peripheral Nervous System Agents: 4 US clinical trials tracked, 3 recruiting.

Peripheral Nervous System Agents is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Theresa Jacob, PhD, MPH, running 1 of these trials.

Enrollment posture brief

Registry condition peripheral-nervous-system-agents

OPEN 3 | RECR 75% | LATE 3 | EARLY 0 | RANK #4115 | SPON 1

Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Peripheral Nervous Syste (th…75%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Peripheral Nervous System Agents

Peripheral Nervous System Agents lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Peripheral Nervous System Agents on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Peripheral Nervous System Agents is recruiting above its size-band peers.

    3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 32Phase 41

Phase Distribution

PhaseTrial count
Phase 3 2
Phase 4 1

Named interventions

Most-linked intervention names on Peripheral Nervous System Agents records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Abdominal wall block with liposomal bupivicaine Drug
1 trials
nebulized ketamine Drug
1 trials
NT 201 Placebo Drug
1 trials
NT 201 Drug
1 trials

US sites by state

Facility locations filed on Peripheral Nervous System Agents trials. A trial with sites in several states counts in each.

New York 2 trials
Maryland 2 trials
California 2 trials
Illinois 1 trials
Georgia 1 trials
Florida 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Peripheral Nervous System Agents page

4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Peripheral Nervous System Agents trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Theresa Jacob, PhD, MPH sponsors the most Peripheral Nervous System Agents trials on record, review their full trial history before evaluating a specific study. See Theresa Jacob, PhD, MPH's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Nervous System Agents condition card totals 4 registered trials; most-linked intervention Abdominal wall block with liposomal bupivicaine; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.